Pharmacology studies and animal model development and related services for drug development
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- 75N95024D00027
- Awardee
-
Lovelace Biomedical Research Institute UEI MBT9RXJJ7428
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Task orders
- 1 $1,000 obligated
Award facts
- Opportunity
-
- Pharmacology Studies and Animal Model Development and Related Services for Drug Development Pre-Solicitation · 75N95023R00004 · Posted Nov 7, 2022
- Combined order value
- $1,000 Current and potential, with all options
- Last date to order 37% complete
- IDV ceiling <1% used
- $48,882,666.00
- Award type
- Multiple award
- Who can order
- Only the awarding agency
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Negotiated Proposal / Quote
- Pricing
- Order Dependent (IDV only)
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this IDV
The National Institute on Drug Abuse awarded a multiple-award indefinite-delivery contract to Lovelace Biomedical Research Institute on August 6, 2024, with a ceiling of $48.8 million for pharmacology studies, animal model development, and related services for drug development. The contract carries no set-aside designation and runs through August 5, 2030.
Work is performed in Albuquerque, New Mexico. The solicitation, posted as a pre-solicitation notice on November 7, 2022, sought comprehensive preclinical research capabilities spanning pharmacology, animal models, disease development, toxicology, and product advancement in support of federal drug development efforts.
A delivery order for a kick-off meeting, issued on August 6, 2024, with a ceiling of $1,000 and completion by September 30, 2024, was placed by the National Center for Advancing Translational Sciences under this IDIQ.
Task orders
| Task order | Ordering agency | Obligated | Awarded |
|---|---|---|---|
| Kick-off meeting for the pharmacology studies and animal model development and related services for drug development… | National Institute on Drug Abuse (NIH) | $1,000 |
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 75N95024D00027?
75N95024D00027 was awarded to Lovelace Biomedical Research Institute by National Institute on Drug Abuse (National Institutes of Health) on August 6, 2024.
How much is contract 75N95024D00027 worth?
Orders under 75N95024D00027 have obligated $1,000. 75N95024D00027's own ceiling is $48,882,666.
How many orders have been placed under contract 75N95024D00027?
1 order has been placed under 75N95024D00027, the latest on August 6, 2024.
Who can order from contract 75N95024D00027?
75N95024D00027 is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract 75N95024D00027 competed?
The extent of competition for 75N95024D00027 was full and open competition. The government received 2 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV